Nifedipine Prolonged Release Tablets

Project Image

Therapeutic Indication

Hypertension (24-hour BP control)
Chronic stable angina
Vasospastic angina
Long-term cardiovascular management
+91 85919 78885

Nifedipine Prolonged Release

Tablet

Nifedipine Prolonged Release Tablets are designed for sustained and controlled release of the drug over 24 hours, ensuring stable blood pressure control and long-lasting anti-anginal effect. This formulation improves patient compliance by reducing dosing frequency and minimizing fluctuations in drug levels. It provides smooth vasodilation and consistent cardiovascular protection.

Speciality Calcium Channel Blocker (Sustained Release)
Tags 24-Hour Control | BP Management | Anti-anginal
Strength
  • 10 mg
  • 20 mg
  • 30 mg
Packing Size
  • 10 Tablets

Check all Tablets Range

Click to know More

Mechanism

Nifedipine inhibits L-type calcium channels in vascular smooth muscle, reducing calcium influx and causing arterial vasodilation. This leads to decreased peripheral vascular resistance and lower blood pressure. The prolonged release formulation ensures gradual drug release, maintaining steady plasma concentrations over 24 hours. This minimizes peak-trough fluctuations, reduces side effects like reflex tachycardia, and provides consistent therapeutic effect. It also improves coronary blood flow, reducing myocardial oxygen demand and preventing angina episodes.

Pharmacokinetics

  • Absorption: Slow and controlled release
  • Distribution: High plasma protein binding
  • Metabolism: Hepatic (CYP3A4)
  • Elimination: Primarily via urine

Side Effects

  • Headache
  • Flushing
  • Dizziness
  • Peripheral edema

Contraindication

  • Severe hypotension
  • Cardiogenic shock
  • Hypersensitivity to Nifedipine

Interaction

  • CYP3A4 inhibitors (ketoconazole, erythromycin)
  • Beta-blockers
  • Grapefruit juice

Warning and Precautions

  • Do not crush or chew SR tablets
  • Monitor blood pressure regularly
  • Use cautiously in heart failure
  • Use under medical supervision